A

AbCellera Tech Stack

Clinical-stage antibody discovery and manufacturing platform

Biotechnology Research Vancouver, British Columbia 501–1,000 employees Founded 2012 Public Company

AbCellera is a public biotechnology company developing antibody-based therapeutics across endocrinology, women's health, immunology, and oncology. The tech stack (SAP, LC-MS, UHPLC, LIMS, Python adoption) and active projects reveal a company scaling from discovery into clinical manufacturing and regulatory compliance—quality assurance, process characterization, and GMP facility buildout dominate the roadmap. Hiring velocity is accelerating across research, engineering, and operations, with notable gaps in leadership (2 director-level roles open) and a strong push into data workflows and forecasting.

Tech Stack 13 technologies

Core StackSAP LC-MS UHPLC LIMS BMS CMMS Chromeleon ChemDraw Prism Excel Google Sheets

AdoptingPython SAP Analytics Cloud

What AbCellera Is Building

◆Challenges

Improving forecast accuracy
Compliance with technical safety bc
Sox compliance assessment
Preventing process downtime
Speeding programs to clinic
Identifying risks and opportunities
Tracking progress against execution
Process robustness improvement
Reducing risk to clinic
Documentation efficiency

▲Active Projects

Qc data architecture design
Mammalian library screening for antibody and antigen engineering
Global cmc strategy development for biologics programs
Building data workflows
New gmp clinical monoclonal antibody manufacturing facility
Process characterization studies
Global supply plans for clinical trials
Global inventory management across depots and sites
Quarterly forecasting processes
Qualifying lc-ms methods for antibodies

Hiring Activity

Accelerating30 roles · 15 in 30d

Department

Research

8

Engineering

4

Finance

4

Ops

4

Healthcare

3

Manufacturing

3

Quality

1

Regulatory

1

Seniority

Mid

7

Senior

7

Manager

5

Intern

3

Director

2

Junior

2

Principal

2

Notable leadership hires: Medical Director

Company intelligence

Find more companies like AbCellera by tech stack, pain points and active projects

Get started free

About AbCellera

AbCellera discovers and develops monoclonal antibody therapeutics using integrated biology, computation, and microfluidic single-cell analysis platforms. The company is clinical-stage, operating across four therapeutic areas and managing manufacturing, supply chain, and regulatory execution at scale. Based in Vancouver with 501–1,000 employees, AbCellera went public and now operates as a vertically integrated platform spanning cell culture, protein analysis, antibody engineering, process development, and GMP manufacturing. Core operational challenges include forecast accuracy, process robustness, compliance (SOX and technical safety), and accelerating the path to clinic.

HeadquartersVancouver, British Columbia

Company Size501–1,000 employees

Founded2012

Hiring MarketsCanada

Frequently Asked Questions

What is AbCellera's tech stack?

Primary tools: SAP (ERP), LC-MS and UHPLC (analytical), LIMS (lab management), BMS, Chromeleon, ChemDraw, Prism, and Excel. The company is adopting SAP Analytics Cloud and Python, indicating movement toward data-driven analytics and automation.

What is AbCellera working on right now?

Key projects: GMP clinical manufacturing facility buildout, global CMC (Chemistry, Manufacturing, Controls) strategy, process characterization and robustness studies, mammalian library screening for antibody engineering, LC-MS method qualification, and data architecture for QC and inventory management.